CAS: 209467-52-7; Ceftobiprole

该化合物是一种五代甲状腺素抗生素,其抗药性广泛,包括抗甲状腺素,抗甲状腺素,抗甲状腺素,抗甲状腺素,包括抗甲状腺素,抗甲状腺素,抗甲状腺素,抗甲状腺素,抗甲状腺素,抗甲状腺素,抗甲状腺素抗乙状腺素,是第五代甲状腺素抗生素抗生素的药,对治疗皮肤和软组织复杂感染(cSTIs)和社区经肺炎(CAP)特别有价值.药物展出有利于药性药用植物,包括良好的组织渗透和平衡的肾排泄情况.其双重目标机制降低了抗药性发展的可能性,使其成为抗感染性抗药性治疗的可靠选择.白素是静脉注射,确保临床环境的生物利用率.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    📜(6R,7R)-7-[(Z)-2-(5-Amino-[1,2,4]Thiadiazol-3-yl)-2-Trityloxyiminoacetylamino]-8-Oxo-3-[(E)-(R)-2-Oxo-[1,3']Bipyrrolidinyl-3-Ylidenemethyl]-5-Thia-1-Azabicyclo[4.2.0]oct-2-Ene-2-Carboxylic Acid 以49的收率获得头孢吡普
    参考文献:Derivatives Of 3-(2-Oxo-[1,3']Bipyrrolidinyl-3-Ylidenemethyl)-Cephams
    标题:Derivatives Of 3-(2-Oxo-[1,3']Bipyrrolidinyl-3-Ylidenemethyl)-Cephams
    摘要:本发明提供了式i的化合物,其中r1为氢,C1-6-烷基,C1-6-烷基取代氟,或c3-6-环烷基;R2为氢或从群组中选择的取代基,该群组包括-ch2C(═chr)-coor,-ch2ocor,-ch(R)ocor,-ch(R)ocoor,-ch(ocor)ocor,-ch2Coch2ocor和r3为氢或从群组中选择的取代基,该群组包括-ch2C(═ch2)-coor,-cooch2C(═chr)-coor,-cooch2ocor,-cooch(R)ocor,-cooch(R)ocoor,-cooch(ocor)ocor,-cooch2Coch2ocor,且其中r2和r3中的一个为氢,另一个不是氢,R为氢或c1-6-烷基;R4为氢或羟基,R5为氢或&ohgr;-羟基烷基;X为ch或n,这些化合物的药学上可接受的盐和它们的盐的水合物.

    海关参考信息

    专利信息


    专利号:US-2024197774-A1
    优先权日:2021-04-16
    标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
    发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
    权利人:UNIV TEXAS
    摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

    专利号:US-10443047-B2
    优先权日:2014-05-01
    标题 :Increasing cellular lipid production by increasing the activity of diacylglycerol acyltransferase and decreasing the activity of triacylglycerol lipase
    发明人:TSAKRAKLIDES VASILIKI; BREVNOVA ELENA E
    权利人:NOVOGY INC
    摘要:Disclosed are methods and compositions for increasing the triacylglycerol content of a cell by up-regulating diacylglycerol acyltransferase and down-regulating triacylglycerol lipase. In some embodiments, a DGA1 protein is expressed and a native TGL3 gene is knocked out, thereby increasing the synthesis of triacylglycerol and decreasing its consumption, respectively.

    专利号:US-9006421-B2
    优先权日:2013-03-14
    标题 :Cephalosporin compositions and methods of manufacture
    发明人:LAI JAN-JI; PATHARE PRADIP M; KOLLA LAXMA; SORET ADRIEN F
    权利人:CUBIST PHARM INC
    摘要:Provided herein is a method for the synthesis of cephalosporin antibiotic compounds comprising the conversion of a protected 7-amino group into a 7-carboxamide moiety in a single step.

    专利号:US-2023364251-A1
    优先权日:2020-08-06
    标 题:Methods for the synthesis of protein-drug conjugates
    发明人:BORCHARDT ALLEN; HUGHES ROBERT MICHAEL
    权利人:CIDARA THERAPEUTICS INC
    摘要:The present invention relates to intermediates and methods for synthesizing protein-drug conjugates that can be used for the treatment of diseases and related conditions.

    专利号:US-10065924-B2
    优先权日:2014-07-22
    标 题 :Preparation and biological evaluation of viridicatumtoxin analogs
    发明人:NICOLAOU KYRIACOS C; HALE CHRISTOPHER R H; NILEWSKI CHRISTIAN; IOANNIDOU HERAKLIDIA; EL MARROUNI ABDELLATIF
    权利人:UNIV RICE WILLIAM M
    摘要:In one aspect, the present invention provides novel derivatives of viridicatumtoxin of the formula wherein the variables are as defined herein. The application also provides compositions, methods of treatment, and methods of synthesis thereof.

    专利号:WO-2022221748-A1
    优先权日:2021-04-16
    标题 :Synthesis of antimicrobial pvp-coated bismuth nanoparticles

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Méndez R, Latorre A, González-Jiménez P. Ceftobiprole medocaril. Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):25-27. doi: 10.37201/req/s01.05.2022. Epub 2022 Apr 22.
    2: Martínez Pérez-Crespo PM, López Cortés LE. Ceftobiprole: a clinical view. Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):32-34. doi: 10.37201/req/s01.09.2021. Epub 2021 Sep 30.
    3: Hsu WH, Hsu CK, Lai CC. Ceftobiprole medocaril for the treatment of pneumonia. Expert Rev Anti Infect Ther. 2023 Jun;21(6):551-563. doi: 10.1080/14787210.2023.2202851. Epub 2023 Apr 18. 10(2):170. doi: 10.3390/antibiotics10020170.

    合成参考文献


    参考文献:10.1517/14728214.9.1.191
    摘要:Georgopapadakou N. Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference. Expert Opin Emerg Drugs. 2004 May;9(1):191–5. doi: 10.1517/14728214.9.1.191.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知